Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Liver Cancer
2021 Dec 21;112:126-140. doi: 10.1159/000521595.
Show Gene links
Show Anatomy links
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
Mosca N, Khoubai FZ, Fedou S, Carrillo-Reixach J, Caruso S, Del Rio-Alvarez A, Dubois E, Avignon C, Dugot-Senant N, Guettier C, Mussini C, Zucman-Rossi J, Armengol C, Thiébaud P, Veschambre P, Grosset CF.
???displayArticle.abstract???
Introduction: Hepatocellular carcinoma and hepatoblastoma are two liver cancers characterized by gene deregulations, chromosomal rearrangements, and mutations in Wnt/beta-catenin (Wnt) pathway-related genes. LHX2, a transcriptional factor member of the LIM homeobox gene family, has important functions in embryogenesis and liver development. LHX2 is oncogenic in many solid tumors and leukemia, but its role in liver cancer is unknown.
Methods: We analyzed the expression of LHX2 in hepatocellular carcinoma and hepatoblastoma samples using various transcriptomic datasets and biological samples. The role of LHX2 was studied using lentiviral transduction, in vitro cell-based assays (growth, migration, senescence, and apoptosis), molecular approaches (phosphokinase arrays and RNA-seq), bioinformatics, and two in vivo models in chicken and Xenopus embryos.
Results: We found a strong connection between LHX2 downregulation and Wnt activation in these two liver cancers. In hepatoblastoma, LHX2 downregulation correlated with multiple poor outcome parameters including higher patient age, intermediate- and high-risk tumors, and low patient survival. Forced expression of LHX2 reduced the proliferation, migration, and survival of liver cancer cells in vitro through the inactivation of MAPK/ERK and Wnt signals. In vivo, LHX2 impeded the development of tumors in chick embryos and repressed the Wnt pathway in Xenopus embryos. RNA-sequencing data and bioinformatic analyses confirmed the deregulation of many biological functions and molecular processes associated with cell migration, cell survival, and liver carcinogenesis in LHX2-expressing hepatoma cells. At a mechanistic level, LHX2 mediated the disassembling of beta-catenin/T-cell factor 4 complex and induced expression of multiple inhibitors of Wnt (e.g., TLE/Groucho) and MAPK/ERK (e.g., DUSPs) pathways.
Conclusion: Collectively, our findings demonstrate a tumor suppressive function of LHX2 in adult and pediatric liver cancers.
Bayard,
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
2018, Pubmed
Bayard,
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
2018,
Pubmed Boyault,
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
2007,
Pubmed Buendia,
Unravelling the genetics of hepatoblastoma: few mutations, what else?
2014,
Pubmed Cairo,
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
2008,
Pubmed Carrillo-Reixach,
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
2020,
Pubmed Coker,
canSAR: update to the cancer translational research and drug discovery knowledgebase.
2019,
Pubmed Cusimano,
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
2007,
Pubmed de La Coste,
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
1998,
Pubmed Doucet-Beaupré,
Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b.
2015,
Pubmed Edgar,
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.
2002,
Pubmed Eichenmüller,
The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
2014,
Pubmed Eicher,
Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.
2013,
Pubmed Genz,
Adenoviral overexpression of Lhx2 attenuates cell viability but does not preserve the stem cell like phenotype of hepatic stellate cells.
2014,
Pubmed Ghousein,
miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
2020,
Pubmed Hirsch,
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
2020,
Pubmed Hooks,
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
2018,
Pubmed Hsu,
Lhx2 regulates the timing of β-catenin-dependent cortical neurogenesis.
2015,
Pubmed Huang,
DUSPs, to MAP kinases and beyond.
2012,
Pubmed Indersie,
Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo.
2018,
Pubmed Indersie,
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.
2017,
Pubmed Kolterud,
Lhx2 is expressed in the septum transversum mesenchyme that becomes an integral part of the liver and the formation of these cells is independent of functional Lhx2.
2004,
Pubmed Kuzmanov,
LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.
2014,
Pubmed Liang,
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
2019,
Pubmed Llovet,
Hepatocellular carcinoma.
2016,
Pubmed Llovet,
Advances in targeted therapies for hepatocellular carcinoma in the genomic era.
2015,
Pubmed Meyers,
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
2017,
Pubmed Miyashita,
Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
2018,
Pubmed Nathalia,
Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review.
2018,
Pubmed Pez,
Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
2013,
Pubmed Porter,
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development.
1997,
Pubmed Ramakrishnan,
The Wnt Transcriptional Switch: TLE Removal or Inactivation?
2018,
Pubmed Rauscher,
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
2015,
Pubmed Rebouissou,
Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
2016,
Pubmed Shi,
miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
2015,
Pubmed Sumazin,
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
2017,
Pubmed Valanejad,
PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma.
2018,
Pubmed von Schweinitz,
Hepatoblastoma: recent developments in research and treatment.
2012,
Pubmed Wandzioch,
Lhx2-/- mice develop liver fibrosis.
2004,
Pubmed Wang,
LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review).
2014,
Pubmed Wang,
Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC.
2013,
Pubmed Wu,
Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
1997,
Pubmed Zhang,
ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.
2015,
Pubmed Zhang,
Fezf2 promotes neuronal differentiation through localised activation of Wnt/β-catenin signalling during forebrain development.
2014,
Pubmed
,
Xenbase Zhou,
Oncogenicity of LHX2 in pancreatic ductal adenocarcinoma.
2014,
Pubmed
